Ana Vujovic
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2026
The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells.
Journal: Blood cancer discovery
Published: December 29, 2025
The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells.
Journal: Blood cancer discovery
Published: December 29, 2025
Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models.
Journal: Science translational medicine
Published: August 06, 2025
Therapy resistance in AML is mediated by cytoplasmic sequestration of the transcriptional repressor IRF2BP2.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
RNA binding protein-directed control of leukemic stem cell evolution and function.
Journal: HemaSphere
Published: January 23, 2024
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target.
Journal: Blood cancer discovery
Published: May 17, 2022
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors.
Journal: Nature communications
Published: July 17, 2021
Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Journal: Cancer research
Published: January 23, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026